GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

By sjmartinez • December 13, 2024

Khadke S, Kumar A, Bhatti A, Dani SS, Al-Kindi S, Nasir K, Virani SS, Upadhyay J, Garcia-Banigan DC, Abraham S, Husami R, Kong Y, Labib S, Venesy D, Shah S, Lenihan D, Vaduganathan M, Deswal A, Fonarow GC, Butler J, Nohria A, Kosiborod MN, Ganatra S. GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction. J Card Fail. 2024 Dec 10:S1071-9164(24)00962-X. doi: 10.1016/j.cardfail.2024.10.448. Epub ahead of print. PMID: 39667523.

Tags: Cardiology/Epi, GLP-1R agonists, Heart failure with preserved ejection fraction, Publications, SGLT 2 inhibitors

Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease

Tjoe B, Pacheco C, Suppogu N, Samuels B, Rezaeian P, Tamarappoo B, Berman DS, Sharif B, Nelson M, Anderson RD, Petersen J, Pepine CJ, Thomson[...]

18F flurpiridaz PET MPI: Imaging characteristics and clinical trials

Maddahi J. 18F flurpiridaz PET MPI: Imaging characteristics and clinical trials. J Nucl Cardiol. 2025 Mar;45S:102175. doi: 10.1016/j.nuclcard.2025.102175. Epub 2025 Mar 28. PMID: 40180504.

Mass spectrometric profiling of primary estrogens and estrogen metabolites in human stool and plasma partially elucidates the role of the gut microbiome in estrogen recycling

Li VW, Dong TS, Funes D, Hernandez L, Kushnir NR, Nair D, Jacobs JP, Reddy ST, Mayer EA, Chang L, Meriwether D. Mass spectrometric profiling[...]